Log In
Print this Print this

Inhaled ISIS (AZD1419)

  Manage Alerts
Collapse Summary General Information
Company Dynavax Technologies Corp.
DescriptionToll-like receptor 9 (TLR9) agonist
Molecular Target Toll-like receptor 9 (TLR9)
Mechanism of ActionToll-like receptor 9 (TLR9) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation
Partner AstraZeneca plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today